Yutaka Isozaki Selected Research

Yutaka Isozaki Research Topics

Disease

7	Ischemia 01/2011 - 01/2004
7	Inflammation (Inflammations) 01/2011 - 01/2004
5	Reperfusion Injury 01/2011 - 01/2004
3	Neoplasms (Cancer) 01/2018 - 09/2009
3	Ulcer 03/2008 - 09/2005
3	Colitis 08/2006 - 03/2006
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 01/2018
2	Disseminated Intravascular Coagulation 10/2011 - 08/2006
2	Stomach Neoplasms (Stomach Cancer) 12/2009 - 12/2008
2	Hemorrhage 03/2008 - 01/2004
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2006 - 03/2006
1	Hepatitis B 01/2021
1	Amebic Dysentery (Amoebic Dysentery) 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2020
1	Carcinoma (Carcinomatosis) 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Chronic Hepatitis C 01/2018
1	Hemangioma (Angioma) 01/2018
1	Hypoproteinemia 01/2016
1	Rheumatoid Arthritis 01/2016
1	Amyloidosis 01/2016
1	Pain (Aches) 10/2011
1	Back Pain (Backache) 10/2011
1	Atrophy 01/2011
1	Hypovolemia 01/2011
1	Gastritis 01/2011
1	Malnutrition (Nutritional Deficiencies) 01/2011
1	Ulcerative Colitis 05/2010
1	Infections 12/2009
1	Lymphangitis 12/2008
1	Dyspnea (Shortness of Breath) 12/2008
1	Stomach Diseases 07/2008
1	Dyspepsia (Indigestion) 03/2008
1	Pancreatitis 08/2006
1	Weight Loss (Weight Reduction) 06/2006
1	Hypoxia (Hypoxemia) 03/2006
1	Body Weight (Weight, Body) 03/2006
1	Hyperemia 12/2005
1	Esophagitis 10/2005
1	Peptic Esophagitis (Reflux Esophagitis) 10/2005
1	Wounds and Injuries (Trauma) 10/2005
1	Stomach Ulcer (Gastric Ulcer) 09/2005

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2016 - 05/2004
5	Messenger RNA (mRNA)IBA 01/2011 - 05/2004
5	Thiobarbituric Acid Reactive SubstancesIBA 03/2006 - 05/2004
4	Phenobarbital (Luminal)FDA Link 01/2018 - 05/2004
4	Hemoglobins (Hemoglobin)IBA 01/2011 - 05/2004
4	CytokinesIBA 12/2009 - 05/2004
4	Peroxidase (Myeloperoxidase)IBA 03/2006 - 05/2004
3	Biomarkers (Surrogate Marker)IBA 01/2011 - 05/2004
3	Free RadicalsIBA 03/2008 - 10/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 10/2005
2	Dacarbazine (DIC)FDA LinkGeneric 10/2011 - 08/2006
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2008 - 12/2005
2	rebamipideIBA 03/2008 - 10/2005
2	Sulfonic AcidsIBA 08/2006 - 03/2006
2	Ethanol (Ethyl Alcohol)IBA 08/2006 - 03/2006
2	Oxygen (Dioxygen)IBA 03/2006 - 10/2005
1	VaccinesIBA 01/2021
1	Metronidazole (Metric)FDA LinkGeneric 01/2020
1	ParaffinIBA 01/2018
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2018
1	Periodic AcidIBA 01/2018
1	Cell Adhesion MoleculesIBA 01/2018
1	Alcian BlueIBA 01/2018
1	MucinsIBA 01/2018
1	Keratins (Keratin)IBA 01/2018
1	tocilizumab (atlizumab)FDA Link 01/2016
1	InterleukinsIBA 01/2016
1	AntibodiesIBA 01/2016
1	Pepsinogen A (Pepsinogen)IBA 01/2011
1	Proteinase-Activated ReceptorsIBA 01/2011
1	Peptide Hydrolases (Proteases)FDA Link 01/2011
1	MicroRNAs (MicroRNA)IBA 05/2010
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2009
1	CollagenIBA 09/2009
1	Docetaxel (Taxotere)FDA Link 12/2008
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 07/2008
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2008
1	nafamostatIBA 08/2006
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 08/2006
1	Tryptases (Tryptase)IBA 08/2006
1	Therapeutic UsesIBA 08/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2006
1	Rosuvastatin Calcium (Crestor)FDA Link 06/2006
1	Dextran SulfateIBA 06/2006
1	Angiotensin IIIBA 03/2006
1	candesartanIBA 03/2006
1	Vitamin E FDA LinkGeneric 03/2006
1	Chemotactic FactorsIBA 10/2005
1	Omeprazole (Prilosec)FDA LinkGeneric 09/2005

Therapy/Procedure

4	Therapeutics 01/2011 - 03/2006
2	Enema (Enemas) 08/2006 - 03/2006
1	Hepatectomy 01/2018
1	Radiofrequency Ablation 01/2018
1	Pancreaticoduodenectomy 01/2018
1	Biological Therapy 01/2016
1	Combination Drug Therapy (Combination Chemotherapy) 12/2008
1	Drug Therapy (Chemotherapy) 12/2008
1	Ligation 10/2005